Neuberger Berman Group LLC Astrazeneca PLC Transaction History

Neuberger Berman Group LLC

$118 Billion
Q1 2024

A detailed history of Neuberger Berman Group LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Neuberger Berman Group LLC holds 5,261,527 shares of AZN stock, worth $411 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

5,261,527

Holding current value

$411 Million

% of portfolio

0.3%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$61.03 - $69.57 $321 Million - $366 Million	5,261,527 New	5,261,527 $356 Million
Q4 2023 Feb 09, 2024	BUY	$61.89 - $69.28 $7.58 Million - $8.49 Million	122,520 Added 4.7%	2,728,472 $184 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $3.56 Million - $3.93 Million	54,830 Added 2.15%	2,605,952 $176 Million
Q2 2023 Aug 11, 2023	BUY	$69.91 - $75.81 $5.04 Million - $5.47 Million	72,118 Added 2.91%	2,551,122 $183 Million
Q1 2023 May 12, 2023	SELL	$63.15 - $71.6 $58.1 Million - $65.8 Million	-919,285 Reduced 27.05%	2,479,004 $172 Million

Q4 2022 Feb 13, 2023	BUY	$54.21 - $70.44 $5.81 Million - $7.55 Million	107,119 Added 3.25%	3,398,289 $230 Million
Q3 2022 Nov 15, 2022	BUY	$53.02 - $135.75 $5.96 Million - $15.3 Million	112,469 Added 3.54%	3,291,170 $181 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $2.05 Million - $2.47 Million	-34,675 Reduced 1.08%	3,178,701 $210 Million
Q1 2022 May 13, 2022	SELL	$55.72 - $67.12 $29.2 Million - $35.2 Million	-523,851 Reduced 14.02%	3,213,376 $213 Million
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $20.8 Million - $24.6 Million	-385,895 Reduced 9.36%	3,737,227 $217 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $62.3 Million - $68.2 Million	1,121,123 Added 37.35%	4,123,122 $247 Million
Q2 2021 Aug 13, 2021	BUY	$48.42 - $60.18 $9.96 Million - $12.4 Million	205,740 Added 7.36%	3,001,999 $180 Million
Q1 2021 May 13, 2021	BUY	$47.16 - $54.44 $81 Million - $93.6 Million	1,718,423 Added 159.43%	2,796,259 $139 Million
Q4 2020 Feb 10, 2021	SELL	$48.52 - $58.02 $2.79 Million - $3.33 Million	-57,475 Reduced 5.06%	1,077,836 $53.9 Million
Q3 2020 Nov 12, 2020	SELL	$53.07 - $61.1 $9.5 Million - $10.9 Million	-178,992 Reduced 13.62%	1,135,311 $62.2 Million
Q2 2020 Aug 13, 2020	SELL	$43.1 - $55.31 $3.46 Million - $4.44 Million	-80,242 Reduced 5.75%	1,314,303 $69.5 Million
Q1 2020 May 14, 2020	SELL	$37.79 - $51.33 $5.04 Million - $6.84 Million	-133,327 Reduced 8.73%	1,394,545 $62.3 Million
Q4 2019 Feb 12, 2020	BUY	$42.46 - $50.46 $13,841 - $16,449	326 Added 0.02%	1,527,872 $76.2 Million
Q3 2019 Nov 13, 2019	SELL	$40.12 - $45.47 $423,466 - $479,935	-10,555 Reduced 0.69%	1,527,546 $68.1 Million
Q2 2019 Aug 13, 2019	SELL	$37.28 - $41.68 $220,995 - $247,079	-5,928 Reduced 0.38%	1,538,101 $63.5 Million
Q1 2019 May 13, 2019	BUY	$35.49 - $43.02 $22.3 Million - $27 Million	627,941 Added 68.55%	1,544,029 $62.4 Million
Q4 2018 Feb 12, 2019	BUY	$36.86 - $41.49 $14.3 Million - $16.1 Million	388,182 Added 73.53%	916,088 $34.8 Million
Q3 2018 Nov 13, 2018	BUY	$34.76 - $39.72 $11.7 Million - $13.3 Million	335,355 Added 174.16%	527,906 $20.9 Million
Q2 2018 Aug 13, 2018	SELL	$34.55 - $37.05 $149,912 - $160,759	-4,339 Reduced 2.2%	192,551 $6.76 Million
Q1 2018 May 08, 2018	BUY	$32.97 - $36.63 $406,816 - $451,977	12,339 Added 6.69%	196,890 $6.89 Million
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $2.31 Million - $2.51 Million	72,068 Added 64.07%	184,551 $6.4 Million
Q3 2017 Nov 15, 2017	BUY	$28.96 - $34.0 $3.26 Million - $3.82 Million	112,483	112,483 $3.81 Million

Others Institutions Holding AZN

# of Institutions

1,244

Shares Held

477M

Call Options Held

5.99M

Put Options Held

5.24M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $242B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Astrazeneca PLC Transaction History